Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-30 @ 9:34 PM
Study NCT ID:
NCT00522834
Status:
TERMINATED
Last Update Posted:
2014-03-04
First Post:
2007-08-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
Sponsor:
Synta Pharmaceuticals Corp.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
4783-08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None